Cargando…
Parkinsonism in the psychiatric setting: an update on clinical differentiation and management
Parkinsonism is seen frequently in patients with psychiatric conditions. Drug-induced parkinsonism (DIP) is the second most common cause of parkinsonism in the general population after Parkinson’s disease (PD) but a range of rarer aetiologies, some of them reversible, should also be considered in pa...
Autores principales: | Powell, Alice, Gallur, Lara, Koopowitz, Leslie, Hayes, Michael William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871718/ https://www.ncbi.nlm.nih.gov/pubmed/33681781 http://dx.doi.org/10.1136/bmjno-2019-000034 |
Ejemplares similares
-
An update on the management of young-onset Parkinson’s disease
por: Klepac, Nataša, et al.
Publicado: (2013) -
Updated Perspectives on the Management of Drug-Induced Parkinsonism (DIP): Insights from the Clinic
por: Feldman, Matthew, et al.
Publicado: (2022) -
Neurocognitive Psychiatric and Neuropsychological Alterations in Parkinson’s Disease: A Basic and Clinical Approach
por: González-Usigli, Héctor Alberto, et al.
Publicado: (2023) -
Update on the Management of Parkinson's Disease for General Neurologists
por: Pirtošek, Zvezdan, et al.
Publicado: (2020) -
Vascular Parkinsonism: A Review on Management updates
por: Udagedara, Thilini B., et al.
Publicado: (2019)